Plasmin in Parasitic Chronic Infections: Friend or Foe?

被引:31
|
作者
Gonzalez-Miguel, Javier [1 ]
Siles-Lucas, Mar [2 ]
Kartashev, Vladimir [3 ]
Morchon, Rodrigo [1 ]
Simon, Fernando [1 ]
机构
[1] Univ Salamanca, Fac Pharm, Lab Parasitol, Salamanca 37007, Spain
[2] CSIC, IRNASA, Lab Parasitol, Salamanca, Spain
[3] Rostov State Med Univ, Dept Infect Dis, Rostov Na Donu, Russia
关键词
HOST FIBRINOLYTIC SYSTEM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BINDING-PROTEIN; ALPHA-ENOLASE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-MECHANISMS; CLONORCHIS-SINENSIS; ONCHOCERCA-VOLVULUS; ACTIVATION SYSTEM; SCHISTOSOMA-BOVIS;
D O I
10.1016/j.pt.2015.12.012
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Plasmin is the final product of the fibrinolytic system, the physiological mechanism responsible for dissolving fibrin clots. Its broad-range proteolytic activity implies that interaction with fibrinolysis and recruitment of plasmin by blood and tissue parasites is an important mechanism that mediates the invasion and establishment of this kind of pathogen in the hosts. However, recent studies have linked an excess of plasmin generated by this interaction with serious pathological events at the vascular level, including the proliferation and migration of arterial wall cells, inflammation, and degradation of the extracellular matrix. Therefore, we present data that support the need to reconsider the role of plasmin, as well as its benefits or drawbacks, in the context of host-parasite relations.
引用
收藏
页码:325 / 335
页数:11
相关论文
共 33 条
  • [1] Inflammation in pathogenesis of chronic pain: Foe and friend
    Fang, Xiao-Xia
    Zhai, Meng-Nan
    Zhu, Meixuan
    He, Cheng
    Wang, Heng
    Wang, Juan
    Zhang, Zhi-Jun
    MOLECULAR PAIN, 2023, 19
  • [2] Antioxidants: Friend or foe?
    Sarangarajan, R.
    Meera, S.
    Rukkumani, R.
    Sankar, P.
    Anuradha, G.
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2017, 10 (12) : 1111 - 1116
  • [3] Neutrophils: Friend or foe in Filariasis?
    Ajendra, Jesuthas
    Allen, Judith E.
    PARASITE IMMUNOLOGY, 2022, 44 (06)
  • [4] Interleukin 18: Friend or foe in cancer
    Palma, Giuseppe
    Barbieri, Antonio
    Bimonte, Sabrina
    Palla, Marco
    Zappavigna, Silvia
    Caraglia, Michele
    Ascierto, Paolo A.
    Ciliberto, Gennaro
    Arra, Claudio
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1836 (02): : 296 - 303
  • [5] Mitogenic action of insulin: friend, foe or 'frenemy'?
    Draznin, B.
    DIABETOLOGIA, 2010, 53 (02) : 229 - 233
  • [6] Inhibition of NETosis for treatment purposes: friend or foe?
    Chamardani, Tahmineh Mohammadi
    Amiritavassoli, Samaneh
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (03) : 673 - 688
  • [7] Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
    Jensen, Agnete Witness Praest
    Simoes, Ana Micaela Carnaz
    Straten, Per Thor
    Olofsson, Gitte Holmen
    CANCERS, 2021, 13 (03) : 1 - 16
  • [8] Androgen Signaling in Prostate Cancer: When a Friend Turns Foe
    Pandey, Swaroop Kumar
    Sabharwal, Usha
    Tripathi, Swati
    Mishra, Anuja
    Yadav, Neha
    Dwivedi-Agnihotri, Hemlata
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2025, 25 (01) : 37 - 56
  • [9] Friend or foe? The dual role of triptolide in the liver, kidney, and heart
    Jiang, Shiyuan
    Wan, Feng
    Lian, Hui
    Lu, Zhihao
    Li, Xueming
    Cao, Dan
    Jiang, Yangyu
    Li, Jian
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [10] The role and its mechanism of intermittent fasting in tumors: friend or foe?
    Zhao, Xu
    Yang, Jing
    Huang, Ruoyu
    Guo, Mengmeng
    Zhou, Ya
    Xu, Lin
    CANCER BIOLOGY & MEDICINE, 2021, 18 (01) : 63 - 73